Qiang Wang

Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study

Giorgio V. Scagliotti, Dale E. Shuster, Joachim von Pawel et al. · Journal of Thoracic Oncology · 2017 · 43 citations · Full text

Medicine, Oncology, Pharmacology +9

Risk Factors for Preoperative and Postoperative Progression of Aortic Regurgitation in Congenital Ruptured Sinus of Valsalva Aneurysm

Yinglong Liu, Aijun Liu, Feng Ling et al. · The Annals of Thoracic Surgery · 2011 · 27 citations

Medicine, Cardiology, Surgery +15

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with <i>EGFR</i> mutations

Jinghui Lin, Ling Xu, Qiang Wang et al. · Oncotarget · 2016 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15

Observed evidence for guideline‐recommended genes in predicting prostate cancer risk from a large population‐based cohort

Jun Wei, Wancai Yang, Zhuqing Shi et al. · The Prostate · 2021 · 19 citations

Medicine, Genetics, Urology +16

Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China

Puyuan Xing, Shouzheng Wang, Qiang Wang et al. · Targeted Oncology · 2019 · 14 citations

Medicine, Oncology, Pharmacology +14